Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on March 5, 2025
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
GlobeNewswire
·
March 5, 2025
LAKE FOREST, Ill., March 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release fourth quarter and full year 2024 financial results on Wednesday, March 12, 2025, after the …
Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates
GlobeNewswire
·
March 5, 2025
On track to declare two in vivo editing development candidates via gene upregulation, one in HSCs and one in liver, in mid-2025 Company to present further in vivo HSC preclinical data and further in vivo preclinical data in one liver indication by year-end …
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 5, 2025
First-in-human global studies initiated for ZW191, an antibody-drug conjugate (ADC) engineered to target folate receptor-⍺ (FR⍺) and ZW171, a bispecific 2 + 1 T cell engager (TCE) targeting mesothelin Acceleration of the planned investigational new drug ( …
Theriva™ Biologics to Participate in the Q1 Investor Summit Virtual
GlobeNewswire
·
March 5, 2025
ROCKVILLE, Md., March 05, 2025 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that Steve …
Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
GlobeNewswire
·
March 5, 2025
MINNEAPOLIS, March 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will …
Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance
GlobeNewswire
·
March 5, 2025
MENLO PARK, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the …
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults
GlobeNewswire
·
March 5, 2025
SOUTH SAN FRANCISCO, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that complete data from the Phase 1b trial of its first-generation oral pill norovirus vaccine candidate in elderly adults (55-80 years) ( …
Enovis to Participate in Upcoming Investor Conferences
GlobeNewswire
·
March 5, 2025
Wilmington, DE, March 05, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Canaccord Genuity …
Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea
GlobeNewswire
·
March 5, 2025
DFD-29 (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) achieved the co-primary and all secondary endpoints with no significant safety issues when administered once daily for 16 weeks Published …
Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
GlobeNewswire
·
March 5, 2025
Phase 1 Dose Expansion Initiated for FT819 Off-the-Shelf CAR T-cell Product Candidate with Fludarabine-free Conditioning in Moderate-to-Severe SLE Completed Type D Meeting with FDA to Enable FT819 Off-the-Shelf CAR T-cell Dose Expansion in Additional B …
WORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective March 6, 2025
GlobeNewswire
·
March 5, 2025
Hangzhou, China, March 05, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its …
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 5, 2025
Initiated Anaphylm™ (epinephrine) Sublingual Film NDA filing process with FDA Anaphylm pre-commercial activities underway; launch expected in Q1 2026, if approved by the FDA Initial Anaphylm pediatric clinical trial results in subjects 7-17 years of age in …
Plus Therapeutics Announces New Employment Inducement Grants
GlobeNewswire
·
March 5, 2025
HOUSTON, March 05, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) …
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
March 5, 2025
WESTLAKE VILLAGE, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …
Natural Alternatives International and CarnoSyn® Brands Publish Clinical Research Demonstrating TriBsyn™ Delivering Exceptional Bioavailability, Increased Efficiency and Paresthesia Elimination
GlobeNewswire
·
March 5, 2025
CARLSBAD, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (NAI) and CarnoSyn® Brands today announced the publication of positive clinical trial results in the journal Food Hydrocolloids for Health showing that TriBsyn™ …
Dr. John Won Grant for Healthcare Students Announces Award to Support Future Medical Professionals
GlobeNewswire
·
March 5, 2025
CHARLOTTE, N.C., March 05, 2025 (GLOBE NEWSWIRE) -- The Dr. John Won Grant for Healthcare Students is now accepting applications for its $1,000 award, designed to support undergraduate students across the United States pursuing careers in healthcare. With …
Andromeda Surgical Announces Strategic Partnerships with Richard Wolf and Quanta System, Accelerating Global Growth and Clinical Development
GlobeNewswire
·
March 5, 2025
SOUTH SAN FRANCISCO, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Andromeda Surgical, a leading innovator in robotic-assisted surgery, is proud to announce strategic partnerships with Richard Wolf and Quanta System, two global leaders in medical technology. …
iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America
GlobeNewswire
·
March 5, 2025
NASHUA, N.H. and TORONTO, March 05, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and RamSoft®, a global leader in cloud-based RIS/PACS radiology solutions for imaging centers …
Holland Bloorview leads national precision health initiative for children and youth
GlobeNewswire
·
March 5, 2025
TORONTO, March 05, 2025 (GLOBE NEWSWIRE) -- Holland Bloorview Kids Rehabilitation Hospital is amongst an elite group of health care organizations across the country that will form the Canadian Precision Health Initiative (CPHI). The initiative will build …
AAPA, PA Foundation leading efforts to improve colorectal cancer screening rates
GlobeNewswire
·
March 5, 2025
ALEXANDRIA, Va., March 05, 2025 (GLOBE NEWSWIRE) -- The American Academy of Physician Associates (AAPA) is proud to lead an effort aimed at improving screening rates for colorectal cancer, which is the third deadliest form of cancer for men and fourth …